K. V. Toyka

5.7k total citations · 1 hit paper
91 papers, 4.1k citations indexed

About

K. V. Toyka is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, K. V. Toyka has authored 91 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Neurology, 34 papers in Cellular and Molecular Neuroscience and 20 papers in Molecular Biology. Recurrent topics in K. V. Toyka's work include Peripheral Neuropathies and Disorders (30 papers), Myasthenia Gravis and Thymoma (22 papers) and Hereditary Neurological Disorders (16 papers). K. V. Toyka is often cited by papers focused on Peripheral Neuropathies and Disorders (30 papers), Myasthenia Gravis and Thymoma (22 papers) and Hereditary Neurological Disorders (16 papers). K. V. Toyka collaborates with scholars based in Germany, United States and Switzerland. K. V. Toyka's co-authors include Hans‐Peter Hartung, Jürgen Zielasek, Richard AC Hughes, Robert D. M. Hadden, AV Swan, David R. Cornblath, Kurt Heininger, Reinhard Hohlfeld, Daniel B. Drachman and M. Naumann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

K. V. Toyka

90 papers receiving 4.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome

1998 676 citations Hans‐Peter Hartung, K. V. Toyka et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. V. Toyka Germany	33	2.4k	1.8k	916	399	397	91	4.1k
Reinhard Kiefer Germany	33	1.6k 0.6×	1.4k 0.8×	958 1.0×	865 2.2×	171 0.4×	60	4.4k
Jean‐Michel Vallat France	37	2.3k 0.9×	2.2k 1.2×	914 1.0×	185 0.5×	461 1.2×	163	4.2k
Ichiro Yabe Japan	37	1.6k 0.7×	1.4k 0.8×	1.6k 1.7×	449 1.1×	198 0.5×	255	4.1k
C Vital France	33	2.0k 0.8×	1.1k 0.6×	2.4k 2.6×	130 0.3×	354 0.9×	203	4.8k
Bruno Giometto Italy	39	3.5k 1.4×	1.2k 0.7×	827 0.9×	490 1.2×	97 0.2×	122	5.3k
Wim Robberecht Belgium	31	1.2k 0.5×	1.1k 0.6×	1.5k 1.6×	299 0.7×	167 0.4×	73	3.8k
O. Lyon‐Caen France	31	1.6k 0.6×	772 0.4×	877 1.0×	377 0.9×	192 0.5×	99	3.9k
Kazim A. Sheikh United States	32	2.1k 0.9×	2.0k 1.1×	589 0.6×	295 0.7×	728 1.8×	73	3.6k
Andreas Weishaupt Germany	29	1.5k 0.6×	1.1k 0.6×	507 0.6×	610 1.5×	176 0.4×	58	2.7k
Yoshigoro Kuroiwa Japan	36	1.7k 0.7×	891 0.5×	1.5k 1.6×	220 0.6×	170 0.4×	211	4.6k

Countries citing papers authored by K. V. Toyka

Since Specialization

Citations

This map shows the geographic impact of K. V. Toyka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. V. Toyka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. V. Toyka more than expected).

Fields of papers citing papers by K. V. Toyka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. V. Toyka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. V. Toyka. The network helps show where K. V. Toyka may publish in the future.

Co-authorship network of co-authors of K. V. Toyka

This figure shows the co-authorship network connecting the top 25 collaborators of K. V. Toyka. A scholar is included among the top collaborators of K. V. Toyka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. V. Toyka. K. V. Toyka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geis, Christian, Marcus Beck, Sibylle Jablonka, et al.. (2009). Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca2+]i rise in embryonic motoneurons. Neurobiology of Disease. 36(1). 191–199. 18 indexed citations

Beer, Meinrad, Herbert Köstler, Stefan Büchner, et al.. (2002). Quantitative analysis of energy metabolism in human muscle using SLOOP 31P-MR-spectroscopy. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 174(5). 573–578. 3 indexed citations

Bayas, Antonios, et al.. (2002). Human cerebral endothelial cells are a potential source for bioactive BDNF. Cytokine. 19(2). 55–58. 39 indexed citations

Schneider, Carsten Q., Ralf Gold, Maria Schäfers, & K. V. Toyka. (2002). Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome. Muscle & Nerve. 25(2). 286–288. 51 indexed citations

Magnus, Tim, Marcus Beck, Ralf Giess, et al.. (2002). Disease progression in amyotrophic lateral sclerosis: Predictors of survival. Muscle & Nerve. 25(5). 709–714. 159 indexed citations

Schneider, Carsten Q., Ralf Gold, Karlheinz Reiners, & K. V. Toyka. (2001). Mycophenolate Mofetil in the Therapy of Severe Myasthenia gravis. European Neurology. 46(2). 79–82. 31 indexed citations

Reiners, Karlheinz, et al.. (2001). Myotone Dystrophie (DM/Curschmann-Steinert-Erkrankung) und proximale myotone Myopathie (PROMM/Ricker-Syndrom). Der Nervenarzt. 72(8). 618–624. 5 indexed citations

Berciano, José, Julien Bogousslavsky, Tobias Brandt, et al.. (2000). Tenth Meeting of the European Neurological Society 18–22 June, 2000, Jerusalem, Israël. Journal of Neurology. 247(S3). 1–217. 17 indexed citations

Schneider, Carsten Q., Y Matsumoto, Kuniko Kohyama, et al.. (2000). Experimental autoimmune myositis in the Lewis rat: lack of spontaneous T-cell apoptosis and therapeutic response to glucocorticosteroid application. Journal of Neuroimmunology. 107(1). 83–87. 12 indexed citations

10.

Naumann, M., Wolfgang H. Jost, & K. V. Toyka. (1999). Botulinum Toxin in the Treatment of Neurological Disorders of the Autonomic Nervous System. Archives of Neurology. 56(8). 914–914. 44 indexed citations

11.

Funa, Keiko, et al.. (1996). Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course.. PubMed. 148(1). 211–23. 47 indexed citations

12.

Giegerich, Gerhard, et al.. (1995). Sequence and diversity of rat T-cell receptor Tcra V8 gene segments. Immunogenetics. 42(4). 304–5. 1 indexed citations

13.

Pollard, John D., Graham K. Harvey, Steffen Jung, et al.. (1995). Activated T cells of nonneural specificity open the blood‐nerve barrier to circulating antibody. Annals of Neurology. 37(4). 467–475. 59 indexed citations

14.

Archelos, Juan J., et al.. (1993). Production and characterization of monoclonal antibodies to the extracellular domain of P0. Journal of Neuroscience Research. 35(1). 46–53. 95 indexed citations

15.

Tesch, Hans, Reinhard Hohlfeld, & K. V. Toyka. (1989). Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patients. Journal of Neuroimmunology. 21(2-3). 169–176. 7 indexed citations

16.

Hartung, Hans‐Peter, Bärbel Schäfer, Tibor Diamantstein, et al.. (1988). Suppression of P2‐T‐Cell Line Mediated Experimental Autoimmune Neuritis by Interleukin‐2 Receptor Blockade. Annals of the New York Academy of Sciences. 540(1). 563–565. 1 indexed citations

17.

Hohlfeld, Reinhard, K. V. Toyka, S J Tzartos, William Carson, & Bianca M. Conti‐Tronconi. (1987). Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit.. Proceedings of the National Academy of Sciences. 84(15). 5379–5383. 82 indexed citations

18.

Hartung, Hans‐Peter, et al.. (1986). Substance P: binding properties and studies on cellular responses in guinea pig macrophages.. The Journal of Immunology. 136(10). 3856–3863. 229 indexed citations

19.

Toyka, K. V., Björn Löwenadler, Kurt Heininger, et al.. (1980). Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.. Journal of Neurology Neurosurgery & Psychiatry. 43(9). 836–842. 23 indexed citations

20.

Drachman, Daniel B., et al.. (1974). PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY. The Lancet. 304(7894). 1409–1412. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact